ICA Signs Letter to Protect Patient Community
On March 23, 2020, the Interstitial Cystitis Association (ICA) signed on to a letter addressed to State Governors, Insurance Commissioners, Medicaid Directors, and Executive Directors Boards of Pharmacy regarding COVID-19 regulatory changes for the patient community. Below is summary of key provisions that were recommended.
- Issuing an emergency regulation requiring that insurers operating within the state allow a one-time 90 day refill of covered prescription medications and lift barriers to obtaining medication from out-of-network pharmacies;
- Preparing for the possibility of supply chain disruptions by requiring insurers to cover off-formulary prescription drugs if there is not a formulary drug available to treat the insured;
- Ensuring prior authorization and reauthorization requirements do not impede access to care and treatment;
- Facilitating authorization of home infusion services and ensuring reimbursement rates appropriately reimburse for such services;
- Requesting authority to extend appeal and fair hearing deadlines to ensure important protections for patients who are seeking access to care and treatment; and
- Seeking flexibilities afforded under section 1135(b)(1)(C) of the Social Security Act.
ICA is committed to protecting the well-being of anyone who is living with IC/BPS.